2025-10-19 11:44:20
2025-10-19 11:44:20
is a new targeted therapy drug targeting the KRAS G12C mutation. Although it has shown significant efficacy in treating specific types of cancer, like most anti-cancer drugs, it may also be associated with a series of side effects. During treatment, patients may experience gastrointestinal reactions and other discomforts, which can be treated under the guidance of a doctor.